UniProt ID | ZN282_HUMAN | |
---|---|---|
UniProt AC | Q9UDV7 | |
Protein Name | Zinc finger protein 282 | |
Gene Name | ZNF282 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 671 | |
Subcellular Localization | Nucleus . | |
Protein Description | Binds to the U5 repressive element (U5RE) of the human T cell leukemia virus type I long terminal repeat. It recognizes the 5'-TCCACCCC-3' sequence as a core motif and exerts a strong repressive effect on HTLV-I LTR-mediated expression.. | |
Protein Sequence | MQFVSTRPQPQQLGIQGLGLDSGSWSWAQALPPEEVCHQEPALRGEMAEGMPPMQAQEWDMDARRPMPFQFPPFPDRAPVFPDRMMREPQLPTAEISLWTVVAAIQAVERKVDAQASQLLNLEGRTGTAEKKLADCEKTAVEFGNHMESKWAVLGTLLQEYGLLQRRLENLENLLRNRNFWVLRLPPGSKGEAPKVPVTFVDIAVYFSEDEWKNLDEWQKELYNNLVKENYKTLMSLDAEGSVPKPDAPVQAEPREEPCVWEQRHPEEREIPMDPEAGAEPLVPAQDASSQVKREDTLCVRGQRGLEERAIPTESITDSPISAQDLLSRIKQEEHQCVWDQQDLADRDIPTDPNSESLISAHDILSWIKQEEQPYPWGPRDSMDGELGLDSGPSDSLLMVKNPPPAPPQPQPQPQPPQPQLQSQPQPQSLPPIAVAENPGGPPSRGLLDDGFQVLPGERGSGEAPPGGDRSTGGGGGDGGGGGGGAEAGTGAGGGCGSCCPGGLRRSLLLHGARSKPYSCPECGKSFGVRKSLIIHHRSHTKERPYECAECEKSFNCHSGLIRHQMTHRGERPYKCSECEKTYSRKEHLQNHQRLHTGERPFQCALCGKSFIRKQNLLKHQRIHTGERPYTCGECGKSFRYKESLKDHLRVHSGGPGPGAPRQLPPPPERD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
111 | Ubiquitination | AIQAVERKVDAQASQ HHHHHHHHHHHHHHH | 30.84 | - | |
111 | Ubiquitination | AIQAVERKVDAQASQ HHHHHHHHHHHHHHH | 30.84 | - | |
156 | Phosphorylation | SKWAVLGTLLQEYGL HHHHHHHHHHHHHHH | 21.82 | - | |
161 | Phosphorylation | LGTLLQEYGLLQRRL HHHHHHHHHHHHHHH | 10.50 | 17053785 | |
190 | Ubiquitination | LRLPPGSKGEAPKVP EECCCCCCCCCCCCC | 67.68 | - | |
228 | Ubiquitination | ELYNNLVKENYKTLM HHHHHHHHHHHHHHH | 43.33 | 21890473 | |
228 | Ubiquitination | ELYNNLVKENYKTLM HHHHHHHHHHHHHHH | 43.33 | 21890473 | |
232 | Ubiquitination | NLVKENYKTLMSLDA HHHHHHHHHHHCCCC | 46.92 | 21890473 | |
232 | Ubiquitination | NLVKENYKTLMSLDA HHHHHHHHHHHCCCC | 46.92 | - | |
245 | Ubiquitination | DAEGSVPKPDAPVQA CCCCCCCCCCCCCCC | 54.06 | - | |
293 | Sumoylation | QDASSQVKREDTLCV CCCCHHCCCCCCEEE | 42.29 | - | |
293 | Ubiquitination | QDASSQVKREDTLCV CCCCHHCCCCCCEEE | 42.29 | - | |
293 | Sumoylation | QDASSQVKREDTLCV CCCCHHCCCCCCEEE | 42.29 | 28112733 | |
313 | Phosphorylation | LEERAIPTESITDSP CCCCCCCCCCCCCCC | 35.93 | 26074081 | |
315 | Phosphorylation | ERAIPTESITDSPIS CCCCCCCCCCCCCCC | 33.01 | 26074081 | |
317 | Phosphorylation | AIPTESITDSPISAQ CCCCCCCCCCCCCHH | 39.44 | 26074081 | |
319 | Phosphorylation | PTESITDSPISAQDL CCCCCCCCCCCHHHH | 18.58 | 25159151 | |
322 | Phosphorylation | SITDSPISAQDLLSR CCCCCCCCHHHHHHH | 24.22 | 26074081 | |
328 | Phosphorylation | ISAQDLLSRIKQEEH CCHHHHHHHHHHHHH | 38.98 | 26074081 | |
331 | Sumoylation | QDLLSRIKQEEHQCV HHHHHHHHHHHHCCC | 51.01 | - | |
331 | Sumoylation | QDLLSRIKQEEHQCV HHHHHHHHHHHHCCC | 51.01 | - | |
331 | Ubiquitination | QDLLSRIKQEEHQCV HHHHHHHHHHHHCCC | 51.01 | - | |
369 | Sumoylation | HDILSWIKQEEQPYP HHHHHHHHHCCCCCC | 45.45 | - | |
369 | Ubiquitination | HDILSWIKQEEQPYP HHHHHHHHHCCCCCC | 45.45 | - | |
369 | Sumoylation | HDILSWIKQEEQPYP HHHHHHHHHCCCCCC | 45.45 | - | |
382 | Phosphorylation | YPWGPRDSMDGELGL CCCCCCCCCCCCCCC | 21.76 | - | |
391 | Phosphorylation | DGELGLDSGPSDSLL CCCCCCCCCCCCCEE | 58.61 | - | |
394 | Phosphorylation | LGLDSGPSDSLLMVK CCCCCCCCCCEEEEC | 43.27 | - | |
507 | Phosphorylation | CPGGLRRSLLLHGAR CCCHHHHHHHHCCCC | 19.55 | 27251275 | |
515 | Phosphorylation | LLLHGARSKPYSCPE HHHCCCCCCCCCCCC | 37.13 | - | |
516 | Acetylation | LLHGARSKPYSCPEC HHCCCCCCCCCCCCC | 42.28 | 26051181 | |
518 | Phosphorylation | HGARSKPYSCPECGK CCCCCCCCCCCCCCC | 27.00 | 30576142 | |
519 | Phosphorylation | GARSKPYSCPECGKS CCCCCCCCCCCCCCC | 31.55 | 30576142 | |
532 | Phosphorylation | KSFGVRKSLIIHHRS CCCCCCCEEEEECCC | 17.78 | 27251275 | |
597 | Phosphorylation | QNHQRLHTGERPFQC HHHCCCCCCCCCHHH | 45.38 | 25159151 | |
625 | Phosphorylation | LKHQRIHTGERPYTC HHCCCCCCCCCCEEC | 38.06 | - | |
653 | Phosphorylation | KDHLRVHSGGPGPGA HHHEEECCCCCCCCC | 42.46 | 25159151 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ZN282_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZN282_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZN282_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of ZN282_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Tyrosine phosphorylated Par3 regulates epithelial tight junctionassembly promoted by EGFR signaling."; Wang Y., Du D., Fang L., Yang G., Zhang C., Zeng R., Ullrich A.,Lottspeich F., Chen Z.; EMBO J. 25:5058-5070(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-161, AND MASSSPECTROMETRY. |